Northern Trust Corp Rhythm Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 502,855 shares of RYTM stock, worth $20.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
502,855
Previous 501,094 0.35%
Holding current value
$20.6 Million
Previous $23 Million 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$39.12 - $52.44 $68,890 - $92,346
1,761 Added 0.35%
502,855 $21.8 Million
Q4 2023

Feb 13, 2024
SELL
$21.39 - $49.64 $62,629 - $145,345
-2,928 Reduced 0.58%
501,094 $23 Million
Q3 2023

Nov 13, 2023
BUY
$15.81 - $27.8 $155,254 - $272,996
9,820 Added 1.99%
504,022 $11.6 Million
Q2 2023

Aug 11, 2023
BUY
$16.32 - $21.15 $5.75 Million - $7.45 Million
352,065 Added 247.69%
494,202 $8.15 Million
Q1 2023

May 15, 2023
BUY
$16.88 - $34.24 $68,127 - $138,192
4,036 Added 2.92%
142,137 $2.54 Million
Q4 2022

Feb 13, 2023
BUY
$22.25 - $30.25 $533,822 - $725,758
23,992 Added 21.03%
138,101 $4.02 Million
Q3 2022

Nov 14, 2022
BUY
$4.3 - $30.85 $12,298 - $88,231
2,860 Added 2.57%
114,109 $2.8 Million
Q2 2022

Aug 12, 2022
SELL
$3.12 - $12.25 $953,590 - $3.74 Million
-305,638 Reduced 73.31%
111,249 $462,000
Q1 2022

May 13, 2022
SELL
$6.13 - $12.24 $74,687 - $149,132
-12,184 Reduced 2.84%
416,887 $4.8 Million
Q4 2021

Feb 08, 2022
BUY
$8.62 - $13.9 $74,450 - $120,054
8,637 Added 2.05%
429,071 $4.28 Million
Q3 2021

Nov 15, 2021
SELL
$11.68 - $20.72 $236,543 - $419,621
-20,252 Reduced 4.6%
420,434 $5.49 Million
Q2 2021

Aug 13, 2021
BUY
$18.52 - $22.55 $106,045 - $129,121
5,726 Added 1.32%
440,686 $8.63 Million
Q1 2021

May 12, 2021
BUY
$20.25 - $39.49 $324,769 - $633,340
16,038 Added 3.83%
434,960 $9.25 Million
Q4 2020

Feb 11, 2021
SELL
$21.17 - $32.61 $294,220 - $453,213
-13,898 Reduced 3.21%
418,922 $12.5 Million
Q3 2020

Nov 16, 2020
SELL
$18.13 - $30.61 $487,751 - $823,500
-26,903 Reduced 5.85%
432,820 $9.38 Million
Q2 2020

Aug 14, 2020
BUY
$14.41 - $25.35 $1.06 Million - $1.86 Million
73,375 Added 18.99%
459,723 $10.3 Million
Q1 2020

May 14, 2020
BUY
$13.16 - $22.9 $302,048 - $525,600
22,952 Added 6.32%
386,348 $5.88 Million
Q4 2019

Feb 14, 2020
BUY
$19.53 - $25.5 $1.37 Million - $1.79 Million
70,310 Added 23.99%
363,396 $8.34 Million
Q3 2019

Nov 13, 2019
BUY
$18.62 - $24.51 $1.46 Million - $1.93 Million
78,588 Added 36.64%
293,086 $6.33 Million
Q2 2019

Aug 13, 2019
SELL
$21.11 - $28.48 $54,210 - $73,136
-2,568 Reduced 1.18%
214,498 $4.72 Million
Q1 2019

May 13, 2019
BUY
$24.76 - $31.66 $153,264 - $195,975
6,190 Added 2.94%
217,066 $5.95 Million
Q4 2018

Feb 12, 2019
SELL
$24.11 - $31.34 $22,132 - $28,770
-918 Reduced 0.43%
210,876 $5.67 Million
Q3 2018

Nov 14, 2018
BUY
$26.99 - $35.85 $1.82 Million - $2.42 Million
67,575 Added 46.86%
211,794 $6.18 Million
Q2 2018

Sep 18, 2018
BUY
$17.02 - $35.2 $216,919 - $448,624
12,745 Added 9.69%
144,219 $4.51 Million
Q2 2018

Aug 14, 2018
BUY
$17.02 - $35.2 $696,560 - $1.44 Million
40,926 Added 45.2%
131,474 $4.11 Million
Q1 2018

May 09, 2018
BUY
$19.9 - $32.25 $246,103 - $398,835
12,367 Added 15.82%
90,548 $1.8 Million
Q4 2017

Feb 14, 2018
BUY
$22.0 - $30.51 $1.72 Million - $2.39 Million
78,181
78,181 $2.27 Million

Others Institutions Holding RYTM

# of Institutions
176
Shares Held
62.4M
Call Options Held
880K
Put Options Held
84.1K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.29B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email